An international team of researchers including Sofya Kulikova, Senior Research Fellow at the HSE University-Perm, found that ketamine, being an NMDA receptor inhibitor, increases the brain's background noise, causing higher ...
Dec 30, 2022
2
373
MIT neuroscientists have discovered that the adult brain contains millions of "silent synapses"—immature connections between neurons that remain inactive until they're recruited to help form new memories.
Nov 30, 2022
0
105
New images from scientists at Cold Spring Harbor Laboratory (CSHL) reveal for the first time the three-dimensional structures of a set of molecules critical for healthy brain function.
Nov 2, 2022
0
38
Myotonic dystrophy type 1 (DM1) is the most common form of muscular dystrophy, characterized by progressive muscle wasting and weakness and caused by abnormally repetitive DNA segments that are transcribed into toxic molecules ...
Jun 29, 2022
0
58
Stroke is a leading cause of disability and death in the U.S., with roughly 800,000 Americans suffering a stroke every year.
Apr 14, 2022
0
74
RIKEN neuroscientists have discovered a surprising mechanism for how neuronal activity in mice is dynamically tuned—with signaling at some synapses increasing, while other synapses go quiet—so as to promote the process ...
Feb 22, 2022
0
106
A new study by University at Buffalo researchers has revealed that the absence of a single interaction within a brain receptor reduces its activity. The discovery advances the understanding of how certain brain diseases arise, ...
Jan 14, 2021
0
41
Neurobiologists at Heidelberg University have discovered how a special receptor at neuronal junctions that normally activates a protective genetic program can lead to nerve cell death when located outside synapses. Their ...
Oct 8, 2020
0
327
If the immune system attacks its own body, it can often have devastating consequences: autoantibodies bind to the body's structures, triggering functional disorders. The receptors for glutamate, a neurotransmitter, can also ...
Feb 24, 2020
0
773
Gladstone researchers, in collaboration with Genentech, a member of the Roche group, have shown therapeutic efficacy of a new experimental drug in mouse models of Alzheimer's disease and a rare genetic form of epilepsy known ...
Jan 14, 2020
0
125
